Arteris designs the network inside other companies' chips
Chip networks
let a chip's parts pass data to each other
Licences
chipmakers pay to use its design
Royalties
a fee on every chip shipped
A modern chip holds processors, memory and special engines that pass data constantly. Arteris sells the design for the network that carries that data, so chipmakers need not build their own.
The company · 2 · What exactly does it sell?
Licences bring 85% of sales; royalties a tenth
Each $1 of sales, first half of 2026
85%10%5%
Licences and supportRoyalties per chip shippedEngineering help
A chipmaker pays a licence fee to design with Arteris's network, then a royalty on each chip it sells. Only 14% of chip projects work first time, so a proven design matters.
The company · 3 · How does it make money?
It still loses money once share pay is counted
26%of 2025 sales paid to staff in shares
$1.2Mloss before share pay last quarter, from $3.5M
$131.4Msigned work not yet billed
Research and office costs rise slower than sales, so the loss shrinks each year. But share pay and selling costs grow as fast as sales, and the share count rose 11% in seven months.
Is it a good business? · 4 · What gives it an edge?
Once a chip family uses it, switching is costly
83
new chip designs started on it in 2025, from 76
About $12.2M
to design a complex chip, against a small fee
A chip's settings, testing and safety approvals are built around the network, so a chipmaker keeps using it for the next generation. One crack: Mobileye now holds rights to a rival's network patents.
Is it a good business? · 5 · What is the catch?
The biggest rival is the customer's own engineers
Qualcomm, Inteleach bought a network business of their own
The largest chipmakers can build this themselves. Baya, a funded start-up, already shares a customer with Arteris.
Is it a good business? · 6 · What does its record show?
Sales more than doubled in four years
Sales, $M
37.9
50.4
53.7
57.7
70.6
93.0
Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025last 12 mo
Sales, latest quarter+48%to $25.8M
Signed yearly income$103.8Myearly contract value plus royalties, up 39%
Forecast$98.5M-$99.5M2026 sales forecast, raised for the third time
Each new dollar of sales loses a little less than the last. The question is whether the loss ends once the cost of paying staff in shares is counted.
Is it a good business? · 7 · How much room is there to grow?
Nobody publishes this market's size today
About $109Mthe last outside count of the market, for 2019
$9.45Bchip designs sold as licences in 2025
+22.2%growth of the part holding these networks
Arteris held about a third in 2019. Growth comes from each chip needing a bigger network, not from more chip projects.
Is it a good business? · 8 · Who is in charge?
The long-time chief owns most of the insider stake
Since 2005Charles Janac as chief executive
About 23%owned by insiders, mostly him
His yearly bonus pays on goals the company does not name, and his share awards vest just for staying. A new finance chief started in September 2026.
The story right now · 9 · Why does AI help Arteris?
AI chips need bigger networks inside them
-57.6%the shares from their 30 June high
6 buys, 1 holdanalysts' ratings
AI chips cram more processors onto one piece of silicon, and every one must pass data quickly. That makes the network inside a bigger and harder job, which is what Arteris sells.
The story right now · 10 · Is Arteris really near a profit?
A company can show profit by leaving out share pay
Staff are paid partly in sharesNo cash leaves the company.
Adjusted figures leave it outThe loss looks small.
But owners payNew shares split the company further.
Counting it, the loss is large57.6% of sales last quarter.
Paying in shares is a real cost: each existing share owns a little less of the company. Analysts expect an adjusted profit soon; we count the share pay too.
The story right now · 11 · What changed lately?
Sales grew 48% and the adjusted loss shrank
+48%third-quarter sales
$1.2Mloss before share pay, from $3.5M
Q4 2026a first adjusted profit is possible, not promised
-57.6%the shares from the June high, with no bad news
Solid quarter
The business kept growing through the fall in the shares. Share pay still dwarfs the adjusted loss, so the profit question stays open.
The story right now · 12 · What is everyone arguing about?
Are the losses ending, or just left out?
Many investors think
An AI chip winner whose losses are about to end
We think
The growth is real, but the losses come from paying staff in shares
We would be wrong if a profit before share pay arrives this quarter while share pay falls below a fifth of sales and growth stays above 25%.
The price and our view · 13 · What is a share worth?
No single value here: it is priced as a bet
We put no single value on a share here, because the business does not yet earn a lasting profit. Instead we ask what the shares pay if the plan works, and what is left if it fails.
The price and our view · 14 · How could we be wrong?
Paid in shares, and customers can build it
Paid in sharesBiggest
Share pay was 26% of 2025 sales.
Customers build itWatch
Big chipmakers keep their own teams.
China is a quarterShowing now
24.5% of 2025 sales, barely growing.
MobileyeUnknown
Whether its newest chips still use Arteris.
Some sales go to companies on a US export blacklist, and costs rose almost as fast as sales in early 2026.
The price and our view · 15 · How will we know?
February tests the profit and the 2027 forecast
Signed yearly income reaches $106MGood sign
An adjusted fourth quarter at zero or betterGood sign
Fourth-quarter results and the 2027 forecast. Companies report every three months; each report is a test of the story.
Our view also changes on price alone: we turn positive if the shares fall far enough to leave room for profit to fall short.
The price and our view · 16 · So, what do we think?
Real growth inside others' chips, profit still a promise
NeutralMedium conviction
Arteris is growing fast inside a rising number of chips. But it still loses money once share pay is counted, and big chipmakers can build their own. The price already pays for profit that is still a promise. Neutral.
↑ ↓ to move · C for contents
What it does
More about the company
Who it is
A modern chip holds processors, memory and specialised engines that constantly pass data to each other. Arteris sells the design for the network that carries that data: it packs each request into small packets and routes them over shared wires.
Chipmakers license the design rather than build it themselves. NXP calls Arteris's products integral to chips it is developing, and AMD uses it inside its AI chips beside its own connection technology. Getting this wrong is costly: only 14% of chip projects work first time.
How it makes money
A customer pays a licence fee per chip design, usually over two to three years, and Arteris engineers help put the network into silicon. Once the chip ships, one to five years later, a royalty arrives on every unit, for seven years or more.
Licences and support were $20.8M of Q2 2026's $24.1M revenue. Royalties are still only about a tenth of revenue, but they are growing faster, and $131.4M of signed work had not yet been counted as revenue.
Growth and profit
What growth costs
Growth is slowly making Arteris less unprofitable: research and office costs rise more slowly than sales, so each new dollar of sales loses less. Selling costs and pay in shares still grow as fast as sales, and the company still loses money on every dollar it sells.
Its record
The numbers
Is it growing?Fast
Sales grew 41% over the twelve months to Sep 2026, faster than the 22% in the year to Dec 2025.
Is it profitable?Losing
Operating margin is −46%, up from −65% in the year to Dec 2023.
Does growth pay off?Pays off
Running costs take 133¢ of each sales dollar, down from 148¢ in the year to Dec 2021.
Does it earn good returns?Poor
Shareholders' money lost 153% a year, down from −114% in the year to Dec 2021.
Is it making cash?Thin
It turned 2.3% of sales into free cash, $2.17M over the last twelve months.
How steady is it?Uneven
Yearly sales growth has ranged from +6.5% to +33% over the last 5 years.
Are shares being diluted?Diluting
The share count rose 125% in 4.8 years, and pay in shares costs 28% of sales.
Why it wins
The evidence
Once a chip family is built around Arteris's network, its settings, testing and, in cars, safety certification are tied to it. Switching means redoing that work on the next design, so customers tend to come back. Design starts rose from 76 to 83 in 2025.
The price is small against the risk: a complex chip design costs about $12.2M, and a faulty network can mean starting again. One crack: Mobileye, a large past customer, now holds rights to another company's network patents.
Who could beat it
The rivals in full
The biggest rival is the customer's own engineers. Qualcomm and Intel each bought a network business to bring the job in-house. Arm sells its own network and bundles one with its processor designs, Cadence launched one in 2024, and Baya, a funded start-up, already shares a customer with Arteris.
The whole licence: the 10-K names in-house teams as the main competitor, and Qualcomm and Intel bought one in 2013 and 2018.
Arm CoreLink NI-700 and the interconnect inside Arm's Compute SubsystemsARM
Non-coherent and coherent networks in chips built on Arm processors, sold in the same licence as the processor; NI-710AE targets cars.
Cadence Janus network-on-chipCDNS
Non-coherent networks for buyers already licensing Cadence's interface IP and tools; first-generation since July 2024 and no named customer.
Baya Systemsprivate
Networks in AI and chiplet designs; backed by Synopsys and Intel Capital and already licensed by Tenstorrent, an Arteris customer.
Intel's network-on-chip patents, sublicensed to MobileyeMBLYINTC
Possibly Arteris's interconnect in Mobileye's driving chips, a historical customer; the filing does not say whose design the chips now use.
Customers' own security verification and general formal toolsin house
Cycuity's checking of hardware security flaws; management says few commercial tools do the job, so the rival is mostly in-house work.
How big it could get
The market and who has signed
The market
Nobody publishes the size of this market today. The last outside count, for 2019, put it near $109M, with Arteris holding about a third.
The wider market for chip designs sold as licences was $9.45B in 2025, and the part holding these networks grew 22.2% that year, faster than the whole. The number of complex chip projects grows slowly, so the growth comes from each chip needing more.
Who has signed
$131.4M of contracted work cannot be cancelled, $67.5M of it due within a year. AMD has licensed the newest network for its AI chips. Management says a large cloud company and a chip design house signed big deals in Q2 2026, but names neither and gives no size.
Who runs it
Leaders, pay and the cash
Who runs it
Charles Janac has run Arteris since 2005 and chairs its board; a new finance chief, Saurabh Sinha, started in September 2026. Insiders own about 23%, almost all of it Janac's. His yearly bonus pays on goals the company does not name, and his share awards vest just for staying, with no profit or share-price test.
What they did with the money
Arteris sold 2.1M new shares for $75.0M and paid for Cycuity partly in shares. It now holds $123.3M of cash and no debt, but each existing share owns a smaller slice of the company.
The last report
The latest report
Arteris's Q3 revenue grew 48% to $25.8M and its adjusted loss shrank
What it did to the thesis Solid quarter
It passed the test on revenue, loss and guide. Growth in contract value slowed a little, and pay in shares still dwarfs the adjusted loss, so the profit question stays open. The view holds at Neutral.
The report
Revenue grew 48% to $25.8M, and the yearly value of contracts plus royalties reached $103.8M, up 39%. The loss before share pay fell to $1.2M from $3.5M a year earlier, and management raised its 2026 revenue guide for the third time, to $98.5M to $99.5M.
Management also pointed to big licence deals with a top U.S. cloud company, two chip makers and a car maker. The guide for the fourth quarter spans break-even, so a first adjusted profit is possible but not promised.
What's happening now
The background
The shares more than doubled over the year, then fell 57.6% from their 30 June high to 14 September with no bad news from the company. The business kept growing through the fall.
A new finance chief started on 8 September, and the Q3 2026 results on 3 November are the first test of the raised guide and of management's hope for a profit before stock pay as soon as Q4.
Where we disagree
Both sides in full
The market
A growing AI chip winner whose losses are about to end, as six buy ratings and one hold say.
We believe
The growth is real, but the losses come from paying staff in shares, and that cost is not shrinking.
The argument
Analysts look at the loss before share pay, which management expects to turn into a profit as soon as Q4 2026. Counting share pay, the Q2 2026 loss was 57.6% of revenue, and share pay alone was 26% of 2025 revenue.
We would be wrong if a profit before share pay arrives in Q4 while share pay falls below a fifth of revenue and growth stays above 25% once Cycuity is in both years.
What it's worth
How we value it
No fair value: the analysts' forecasts show no lasting operating profit after stock pay, so a value built on earnings would rest on a guess; the bet prices it instead.
What could go wrong
Every risk
The risks
Paid in shares
Share pay was 26% of 2025 revenue, and shares outstanding rose 11% in seven months.
Customers can build it
The biggest chipmakers keep their own network teams, and Qualcomm and Intel each bought one to stop paying.
China is a quarter
China was 24.5% of 2025 revenue and barely grew, and some sales go to companies on a U.S. export blacklist.
A big customer may leave
Mobileye now holds rights to another company's network patents and no longer names Arteris in its annual report.
Costs keep pace
Costs rose almost as fast as revenue in early 2026, and the expected loss was widened twice this year.
What we still do not know
How much of 2026 revenue Cycuity brought. Arteris calls the deal too small to report separately.
Whether Mobileye's newest driving chips still use Arteris's network.
How big this market is today. The research firm that counts it sells the figure.
Which cloud company standardised on Arteris, and how large the deal is.
What changes our view
Every route to a new view
Every route to a new view
→ Attractive
The shares fall until the company is valued at 9 times sales, leaving room for profits to fall short. The yearly value of contracts plus royalties reaches $106M or more by the end of 2026.
→ Unattractive
Arteris guides 2027 revenue growth below 15%. The shares rise until the company is valued at 18 times sales, which would need about 41% growth a year.
The next test
It supports the case if
ACV plus royalties at or above $106M, a Q4 non-GAAP operating result of zero or better, and 2027 revenue growth guided at 15% or more.
It pressures the case if
ACV plus royalties below $103M, a Q4 non-GAAP operating loss above $1M, or 2027 revenue growth guided below 15%.
We would also be wrong if
Fewer chip designs start on Arteris in 2026 than the 83 of 2025.
NXP, AMD or another top customer names a different network supplier, or its own.
Royalties grow less than 20% a year for two quarters in a row.
The verdict
Scores and how we weighed it
The scores
Growth
3 of 4
Business quality
3 of 4
Financial position
4 of 4
Execution record
3 of 4
Per share capture
2 of 4
Potential
2 of 4
Risk profile
3 of 4
Valuation
2 of 4
Evidence quality
3 of 4
How we weighed it
ValueMixed
No fair value is drawn: the forecasts show no lasting profit after stock pay, so the bet prices it.
BusinessPositive
Customers rarely switch, and royalties grow with every chip shipped.
GrowthMixed
Revenue and contract value grow, though part of this year's growth was bought.
RisksNegative
Share pay is a large slice of revenue, big chipmakers can build their own, and China is a large share.
RivalsMixed
No filed rival compares directly; the largest customers are also the likeliest rivals.
The groupMixed
It sits in none of our ranked groups; AI chip design spending moves it.
Latest newsMixed
The last report passed the test on revenue and guide, but share pay still dwarfs the adjusted loss.
In plain words
Royalty
A fee paid to the owner of a design each time it is used, here for every chip a customer ships. The owner earns it without making anything itself.